MindWalk Holdings Corp. Common Stock (HYFT) Stock
NASDAQ · HYFT
1.36
Fundamentals
Market cap
$64.07M
Price / Earnings ratio
-5.0x
Price / Sales ratio
5.3x
Price / Book ratio
12.4x
Return on assets
-0.5%
Ex-Dividend date
N/A
Last payment date
N/A
Dividend amount
$0.00
Dividend yield
0.0%
Debt / Equity ratio
N/A
Latest news
About MindWalk Holdings Corp. Common Stock
MindWalk Holdings Corp is a Bio-Native AI company transforming drug discovery and development. Powered by patented HYFT technology and the LensAI platform, MindWalk unifies sequence, structure, function, and literature into a single computational language and closes the loop with an integrated, full-stack wet lab. The platform supports rapid epitope mapping, de novo molecular design, in silico vaccine exploration, and population-scale biologics analytics that help turn insights into validated candidates at speed.
SectorHealthcare
IndustryBiotechnology
Employees74
CEODr. Jennifer Lynne Bath Ph.D.
IPO DateJan 3, 2017
HeadquartersAustin, TX
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Dr. Jennifer Lynne Bath Ph.D. | CEO, President & Non-Independent Director | — |
| Mr. Richard Scott Areglado | Chief Financial Officer | 1964 |
| Dr. Thomas Lynch Ph.D. | Chief Business Officer | — |
| Ms. Kari Graber | Vice President of Commercial Services | — |
| Dr. Shuji Sato | Vice President of Innovative Solutions | — |
| Mr. Dirk Van Hyfte M.D., Ph.D. | Chief Technology Officer | — |
| Mr. Frederic Chabot | Head of Corporate Development | — |
| Ms. Ingrid Brands M.D., Ph.D. | Chief Innovation & Strategy Officer | — |
| Ms. Lori Anderson | Vice President of Brand Marketing and Creative | — |
Fundamentals
Valuation
Market cap$64.07M
Price-to-sales ratio5.28
Price-to-book value12.41
Price-earnings ratio-5.00
Return on Equity-86.00%
Return on SalesN/A
Return on AssetsN/A
PEG ratioN/A
Earnings Per Share
Earnings Per Share$-0.26
Income Statement
Average volume153,102
EBITDA$-9.19M
1 year high (52w)$2.99
1 year low (52w)$0.99
Dividend
Ex dividend dateN/A
Dividend amount$0.00
Dividend yield0.00%
Last payment dateN/A
Dividend yield (TTM)N/A
Next earnings reportN/A
Solvency
Debt-to-equity ratioN/A



